Jean-Yves Rotte Geoffrey

Find out how GSK global procurement is working with the business to develop a culture to recognise and manage risk and innovation. Addressing how innovation is being done at product and process levels as well as with partners and how risk is being managed in business environments including China, this interactive session offers new insights from a truly thought-provoking business leader.

• How cultural change in GSK procurement is driving new priorities around innovation
• How GSK procurement is stepping up the link between suppliers and innovation
• Lessons learned and recent experiences managing risk in China
• Emerging challenges around sourcing innovation and managing risk with start-ups

As Pharma businesses increasingly turn to Innovation as the competitive differentiator in both existing and new markets find out how senior business leaders believe procurement will play a new and exciting role during this interactive discussion. With representatives from big, medium and smaller Pharma businesses, this panel offers you a comprehensive view on a critical topic.

• Exploring how and why ‘Innovation’ is experiencing a renaissance in Pharma as a business-wide priority
• What is the business case and what are the metrics to use when targeting ‘more innovation’ through procurement?
• Examples from different Pharma businesses as they address Innovation through procurement
• When will ‘Innovation’ not ‘Savings’ be the driver for better procurement?